Marco Aveggio Merello
Direttore/Membro del Consiglio presso Grupo Wiese
Profilo
Marco Aveggio Merello has worked as a Director at Grupo Wiese and ZEV Biotech.
Posizioni attive di Marco Aveggio Merello
| Società | Posizione | Inizio |
|---|---|---|
Grupo Wiese
 Grupo Wiese Financial ConglomeratesFinance Grupo Wiese operates as a group of companies that provides investment management services. Its service portfolio includes real estate, shipping, financial, insurance, and logistics sector. The company was founded by Augusto Wiese Eslava and is headquartered in Lima 27, Peru. | Direttore/Membro del Consiglio | - |
ZEV Biotech
 ZEV Biotech Medical SpecialtiesHealth Technology ZEV Biotech is an Argentinean biotechnology company that specializes in molecular diagnostic kits for hereditary and infectious diseases, as well as pharmacogenomics of polar iris medicines technology. The company is based in Buenos Aires, Argentina. The company's technology is easy and cost-effective to implement in any laboratory, hospital, clinic, or other health institutions, both public and private, and adapts to the requirements of each one. The company was founded in 2014 by Maximiliano Irisarri, who has been the CEO since 2014. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Grupo Wiese
Grupo Wiese Financial ConglomeratesFinance Grupo Wiese operates as a group of companies that provides investment management services. Its service portfolio includes real estate, shipping, financial, insurance, and logistics sector. The company was founded by Augusto Wiese Eslava and is headquartered in Lima 27, Peru. | Finance |
ZEV Biotech
ZEV Biotech Medical SpecialtiesHealth Technology ZEV Biotech is an Argentinean biotechnology company that specializes in molecular diagnostic kits for hereditary and infectious diseases, as well as pharmacogenomics of polar iris medicines technology. The company is based in Buenos Aires, Argentina. The company's technology is easy and cost-effective to implement in any laboratory, hospital, clinic, or other health institutions, both public and private, and adapts to the requirements of each one. The company was founded in 2014 by Maximiliano Irisarri, who has been the CEO since 2014. | Health Technology |
- Borsa valori
- Insiders
- Marco Aveggio Merello
